Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.
Molecular Weight:
148 kDa
Purity:
99.60%
CAS Number:
[477202-00-9]
Target:
Others|||Immunology/Inflammation related
T9906
* VAT and and shipping costs not included. Errors and price changes excepted